110 related articles for article (PubMed ID: 3829001)
1. Development and characterization of a human colon adenocarcinoma xenograft deficient in thymidine salvage.
Houghton PJ; Houghton JA; Germain G; Torrance PM
Cancer Res; 1987 Apr; 47(8):2117-22. PubMed ID: 3829001
[TBL] [Abstract][Full Text] [Related]
2. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
3. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
[TBL] [Abstract][Full Text] [Related]
4. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
[TBL] [Abstract][Full Text] [Related]
6. Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.
Schultz RM; Patel VF; Worzalla JF; Shih C
Anticancer Res; 1999; 19(1A):437-43. PubMed ID: 10226579
[TBL] [Abstract][Full Text] [Related]
7. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
8. Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.
Houghton PJ; Houghton JA; Hazelton BJ; Radparvar S
Invest New Drugs; 1989 Apr; 7(1):59-69. PubMed ID: 2661484
[TBL] [Abstract][Full Text] [Related]
9. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
Howell SB; Jenkins RS; Streifel J
Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623
[TBL] [Abstract][Full Text] [Related]
10. Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.
Houghton PJ; Germain GS; Hazelton BJ; Pennington JW; Houghton JA
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1377-81. PubMed ID: 2537495
[TBL] [Abstract][Full Text] [Related]
11. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouse.
Stragand JJ; Barlogie B; White RA; Drewinko B
Cancer Res; 1981 Sep; 41(9 Pt 1):3364-9. PubMed ID: 7260902
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin response of two human tumor xenografts using a double-radiolabel organ culture method.
Sullivan JL; Sullivan LG
Neoplasma; 1989; 36(6):685-90. PubMed ID: 2615871
[TBL] [Abstract][Full Text] [Related]
14. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
[TBL] [Abstract][Full Text] [Related]
15. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
16. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
17. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
Balzarini J; De Clercq E; Ayusawa D; Seno T
Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
[TBL] [Abstract][Full Text] [Related]
19. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.
Dangles-Marie V; Pocard M; Richon S; Weiswald LB; Assayag F; Saulnier P; Judde JG; Janneau JL; Auger N; Validire P; Dutrillaux B; Praz F; Bellet D; Poupon MF
Cancer Res; 2007 Jan; 67(1):398-407. PubMed ID: 17210723
[TBL] [Abstract][Full Text] [Related]
20. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
